IntrinsicIntrinsic
← Scroll for more →

Financial Statements — CTXR

Balance Sheet

(in millions USD)
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Cash & Equivalents17.014.597.724.256.090.031.103.2517.9112.5620.3526.4833.2829.0736.8941.7148.0455.7665.4270.07
Accounts Receivable0.691.084.05----------------------------------
Inventory22.6322.6622.6422.2917.2115.3414.38--------------------------
Total Current Assets43.3331.6937.9527.9324.6118.3718.3314.2228.0121.5728.2134.3741.1134.9042.3244.5650.8358.2667.9472.81
Property, Plant & Equipment------------------0.000.000.000.000.000.000.000.000.010.010.01
Goodwill9.359.359.359.359.359.359.359.359.359.359.359.359.359.359.359.359.359.359.359.35
Total Non-current Assets*98.92100.85102.45103.00103.07103.11102.38102.4369.0869.1469.1969.2469.2969.3469.3969.4469.4869.5369.5769.61
Total Assets142.26132.54140.39130.94127.68121.48120.70116.6597.0990.7197.40103.61110.40104.24111.71114.00120.32127.79137.52142.43
Accounts Payable8.049.4511.0213.6910.099.377.364.931.662.672.652.933.082.731.541.171.691.711.791.28
Total Current Liabilities51.6555.0238.2144.9151.8449.8844.8135.814.154.175.585.785.796.214.544.534.464.027.343.98
Total Non-current Liabilities*14.708.448.728.508.278.036.986.746.656.576.496.406.316.226.136.045.525.575.625.66
Total Liabilities66.3563.4646.9253.4160.1257.9151.7842.5510.8110.7412.0712.1812.1012.4310.6710.579.989.5912.969.65
Retained Earnings(277.12)(268.26)(247.02)(238.80)(230.84)(222.05)(211.14)(201.37)(190.58)(180.01)(171.46)(162.23)(152.29)(143.81)(133.28)(129.69)(121.70)(112.83)(105.27)(96.05)
Total Stockholder Equity66.6161.5479.9667.5565.0660.6665.4170.0885.6879.3784.7390.8397.7091.21100.43102.83109.74117.60123.96132.18
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Total Revenue1.491.673.94------------------------0.000.09----0.00
Cost of Revenue0.490.330.79----------------------------------
Gross Profit1.001.343.15----------------------------------
Research & Development1.051.631.601.641.623.772.132.912.763.612.622.883.764.733.453.864.893.455.462.29
Selling, General & Admin6.1526.395.723.914.454.795.395.494.814.293.664.173.734.792.602.723.023.122.902.45
Total Operating Expenses12.7333.5312.178.448.7911.2610.0411.0510.6310.979.3410.128.6710.697.257.558.927.599.265.20
Operating Income(11.73)(32.19)(9.02)(8.44)(8.79)(11.26)(10.04)(11.05)(10.63)(10.97)(9.34)(10.12)(8.67)(10.69)(7.25)(7.55)(8.92)(7.59)(9.26)(5.20)
Interest Expense0.20------------------------------------0.00
Pretax Income(12.03)(28.34)(9.13)(8.48)(8.94)(11.25)(10.02)(10.93)(10.43)(8.40)(9.09)(9.80)(8.34)(10.38)(3.45)(7.41)--------
Tax Provision(0.11)(0.23)0.260.260.260.260.260.140.140.140.140.140.140.140.14---------0.00
Net Income(11.92)(28.11)(9.39)(8.74)(9.20)(11.51)(10.28)(11.08)(10.57)(8.54)(9.23)(9.94)(8.48)(10.53)(3.59)(7.99)(8.86)(7.56)(9.23)(4.96)
Basic EPS(0.34)(0.95)(0.38)(0.01)(0.80)(1.27)(1.30)(1.61)--------(0.06)(0.07)(0.02)(0.05)(0.06)(0.05)----
Diluted EPS(0.34)(0.95)(0.38)(0.01)(0.80)(1.27)(1.30)(1.61)--------(0.06)(0.07)(0.02)(0.05)(0.06)------
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Operating Cash Flow(8.68)(1.30)(13.01)(11.88)(5.41)(4.54)(4.73)(5.91)(8.37)(7.79)(6.14)(6.80)(9.58)(7.85)(4.82)(6.33)(7.71)(9.67)(4.65)(5.59)
Capital Expenditures----------------------------------------
Investing Cash Flow(2.00)(0.60)(4.40)--------------------------------(40.00)
Financing Cash Flow23.09(1.23)20.8815.7911.473.472.57(3.75)13.72-----0.0013.800.03----------0.00
← Scroll for more columns →